ASCEND BY NTHRYS
Research Abroad Products

Genetics Project Topics

Browse all focused areas across all project categories under this field.

Showing 793–804 of 2020 project topics
Citrin Deficiency CTLN2 Sequencing and Reporting Software
An integrated bioinformatics pipeline that performs targeted deep sequencing of SLC25A13 with automated variant calling and clinical interpretation tailored to neonatal screening workflows. This white-label software solution captures margin-based revenue from regional diagnostic labs and newborn screening programs requiring scalable, compliant reporting infrastructure.
Genetic Basis of Liver Disease Click to view more details →
High-Throughput Epigenetic Screening Tools for Target Validation
Automated platforms rapidly assess epigenome editing efficiency across thousands of candidate regulatory regions using next-generation sequencing and chromatin immunoprecipitation assays. This reduces target validation costs and enables contract research organizations to offer premium screening services to biopharma clients.
Epigenome Editing Biotechnology Click to view more details →
Autoimmune Hepatitis HLA Genotype Risk Stratification Engine
A proprietary AI model that analyzes HLA Class II alleles and non-HLA genetic modifiers to predict autoimmune hepatitis severity and treatment response patterns. This B2B service delivers value to gastroenterology clinics and pharmaceutical companies through patient risk stratification licensing and clinical trial patient identification contracts.
Genetic Basis of Liver Disease Click to view more details →
Chromatin Accessibility Modulation Software for Cell Engineering
Proprietary algorithms and tools design optimized epigenome edits that enhance chromatin accessibility at therapeutic target loci in engineered cell therapies. Companies monetize through licensing fees and royalties by enabling CAR-T and stem cell therapy manufacturers to improve functional cell potency.
Epigenome Editing Biotechnology Click to view more details →
Multiplexed Epigenome Editing Reagent Kits for Research
Ready-to-use kits combine multiple engineered epigenome editing components targeting different histone modifications and DNA states simultaneously for complex trait studies. Reagent manufacturers capture recurring revenue through kit subscriptions and generate data licensing opportunities from institutional research programs.
Epigenome Editing Biotechnology Click to view more details →
Triglyceride Metabolism Gene Panel Commercial Testing Service
A comprehensive genetic testing service analyzing APOE, LIPC, APOB, and GPIHBP1 variants in the context of liver lipid metabolism and NAFLD progression. This direct-to-consumer and B2B service model generates revenue through test pricing, third-party payer reimbursement, and data partnerships with metabolic disease research consortiums.
Genetic Basis of Liver Disease Click to view more details →
Epigenetic Biomarker Analytics Platform for Precision Medicine
Integrated diagnostics platform identifies patient-specific epigenetic signatures predicting response to epigenome-based therapeutics and enabling stratified clinical trial enrollment. Healthcare providers and diagnostics companies generate revenue through per-test fees while improving clinical outcomes and reducing adverse drug events.
Epigenome Editing Biotechnology Click to view more details →
Hepatic Fibrosis Genetic Risk Prediction API Platform
A REST API service that integrates hepatitis B/C viral genetics with host genetic polymorphisms in collagen and inflammatory pathway genes to predict cirrhosis risk. Healthcare technology companies and EHR vendors license this API on usage-based models, creating scalable recurring revenue while supporting precision medicine interventions.
Genetic Basis of Liver Disease Click to view more details →
Schizophrenia Common and Rare Variant Contributions
Studying how common GWAS variants, rare protein-truncating variants, and CNVs together contribute to schizophrenia genetic architecture and risk.
Genetic Architecture of Psychiatric Disorders Click to view more details →
Autism CNV and De Novo Variant Landscape
Characterizing the spectrum of autism-associated de novo mutations, CNVs, and common variants for understanding ASD genetic heterogeneity.
Genetic Architecture of Psychiatric Disorders Click to view more details →
Bipolar Disorder Genetic Overlap with Schizophrenia
Using genetic correlation and cross-disorder GWAS for quantifying shared genetic architecture between bipolar disorder and schizophrenia.
Genetic Architecture of Psychiatric Disorders Click to view more details →
ADHD Polygenic Risk and Neurodevelopment
Studying ADHD polygenic risk score associations with cognitive phenotypes and neurodevelopmental outcomes in population cohort studies.
Genetic Architecture of Psychiatric Disorders Click to view more details →